UBA1 and vasculitis: The recently described VEXAS syndrome, which is associated with vasculitis, polychondritis and other RMD manifestations, should be considered and excluded with molecular (UBA-1) testing as this would be a potential indication for allogeneic HSCT (rather than autologous HSCT) in carefully selected patients [73].